ENSAYO INTERNACIONAL, ALEATORIZADO Y CONTROLADO PARA EL TRATAMIENTO DEL SARCOMA DE EWING DE DIAGNÓSTICO RECIENTE.

Editorial Material. 10.1097/DAD.0000000000000470. 2017

Acute Necrotic Plaque in an Immunocompromised Host

Editorial Material. 10.1097/DAD.0000000000000471. 2017

Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.

Ballesta-López O; (...); Poveda-Andrés JL

Article. 10.1177/1078155220915953. 2020

Adjuvant chemoradiation in gastric cancer: long-term outcomes and prognostic factors from a single institution

Bruixola, G; (...); Aparicio, J

Article. 10.5301/tj.5000344. 2015

Adolescent cancer care: What has changed in Spain in the past decade?

Garrido Colino, Carmen; (...); Vagace Valero, Jose Manuel

Article. 10.1016/j.anpede.2023.01.003. 2023

Adolescent cancer care: What has changed in Spain in the past decade?

Garrido Colino, Carmen; (...); SEHOP

Article. 10.1016/j.anpedi.2022.09.012. 2023

Advances in emerging drugs for the treatment of neuroblastoma

Berlanga, P, Cañete A, Castela, V

Review. 10.1080/14728214.2017.1294159. 2017

Aflibercept in exudative age related macular degeneration refractory to ranibizumab.

Ruiz Ramos J; (...); Gallego-Pinazo R

Article. 10.1016/j.oftal.2015.07.018. 2015

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP).

Riechelmann RP; (...); Sobrero A

Article. 10.1016/j.clcc.2019.05.003. 2019

Alectinib in pediatric patients with solid or CNS tumors harboring ALK-fusions: Emerging pharmacokinetic data from the iMATRIX alectinib phase I/II open-label, multi-center study

Doz, Francois; (...); Gajjar, Amar J.

Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.3098. 2024

An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens

Sobas, M; (...); GATLA Cooperative Grp

Article. 10.1080/10428194.2018.1516875. 2019

An exosome-based liquid biopsy predicts depth of response and survival outcomes to cetuximab and panitumumab in metastatic colorectal cancer: The EXONERATE Study.

Xu, Caiming; (...); Goel, Ajay

Article. 10.1158/1078-0432.CCR-24-1934. 2025

An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib

Diaz-Beveridge, R; (...); Aparicio, J

Article. 10.1007/s12094-017-1720-4. 2018

Analysing criteria for price and reimbursement of orphan drugs in Spain.

Badia, X; (...); Tort, M

Article. 10.7399/fh.11147. 2019

Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital

Valero García S; (...); Poveda Andrés JL

Article. 10.1177/10781552211038518. 2021

Anti-D Alloimmunization after RhD-Positive Platelet Transfusion in RhD-Negative Women under 55 Years Diagnosed with Acute Leukemia: Results of a Retrospective Study

Villalba, A; (...); Solves, P

Article. 10.1159/000488804. 2018

Antimicrobial stewardship programme implementation in a medical ward

Ruiz, J; (...); Poveda, JL

Article. 2018

Antimicrobial stewardship programme in critical care medicine: A prospective interventional study

Ruiz, J; (...); Catellanos, A

Article. 10.1016/j.medin.2017.07.002. 2018

Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ

Letter. 10.1111/jdv.19432. 2023

ASSESSMENT OF A NOVEL READY-TO-USE TEMOZOLOMIDE ORAL SUSPENSION IN CHILDREN WITH SOLID TUMORS: RESULTS OF TEMOKIDS, A POPULATION PHARMACOKINETIC, ACCEPTABILITY AND SAFETY PHASE-1 STUDY

Abbou, Samuel; (...); Metayer, Lucy

Meeting Abstract. 2023

Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin

Rodriguez-Veiga, R; (...); spanish PETHEMA group

Article. 10.1007/s00277-017-3004-z. 2017

Assessment of the dicentric chromosome assay as a biodosimetry tool for more personalized medicine in a case of a high risk neuroblastoma I-131-mIBG treatment

Chimeno, JM; (...); Montoro, A

Article. 10.1080/09553002.2019.1549755. 2018

Assessment of the quality of sample labelling for clinical research.

Pérez-Huertas P; (...); Poveda-Andrés JL

Article. 10.7399/fh.2016.40.2.9753. 2016

Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation

Sánchez-Lázaro I; (...); Aliño SF

Article. 10.2217/pgs.15.39. 2015

Asymptomatic Annular Plaques in a 67-Year-Old Man: Challenge.

de Unamuno Bustos B; (...); Estrada RB

Article. 10.1097/DAD.0000000000000506. 2017

Atypical B-Cell Acute Lymphoblastic Leukemia with iAMP21 in the Context of Constitutional Ring Chromosome 21: A Case Report and Review of the Genetic Insights.

Gil, Jose Vicente; (...); Llop, Marta

Article. 10.3390/ijms26010357. 2025

Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Espanol De Trasplante de Medula Osea en Nimos (GETMON) and the Grupo Espanol de Trasplante Hematopoyetico (GETH)

Gonzalez-Vicent, M; (...); Sanz, MA

Review. 10.1016/j.tmrv.2018.02.005. 2018

Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.

Iglesias Gómez R; (...); Poveda Andrés JL

Article. 10.1136/ejhpharm-2021-002741. 2021

Barriers and facilitators to implementation of the interoperable Survivorship Passport (SurPass) v2.0 in 6 European countries: a PanCareSurPass online survey study.

van den Oever, Selina R; (...); Pluijm, Saskia M F

Article. 10.1007/s11764-023-01335-y. 2023

Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study.

de Beijer IAE; (...); Pluijm SMF

Article. 10.1007/s11764-023-01498-8. 2023

Basic and Clinical Approaches for Fertility Preservation and Restoration in Cancer Patients

Medrano, JV; (...); Pellicer, A

Review. 10.1016/j.tibtech.2017.10.010. 2018

Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018

Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

Poveda-Andrés JL, Bosó-Ribelles V

Article. 10.1016/j.thromres.2018.12.027. 2019

Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.

Fernandez Rivera C; (...); Hernandez D

Article. 10.1111/ctr.14550. 2022

Biosimilares: viejas polemicas con nuevos argumentos.

Editorial Material. 10.7399/fh.2015.39.3.8978. 2015

BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric Population

Perez-Huertas, P; (...); Poveda-Andres, JL

Article. 10.1177/1043454216631952. 2017

Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP)

Fuster, JL; (...); Ramirez, M

Article. 10.1111/bjh.16647. 2020

Blinatumomab to improve the outcome of children with relapsed B-cell acute lymphoblastic leukemia.

Fuster JL; (...); Dapena JL

Letter. 10.1007/s12094-021-02590-0. 2021

Breakthrough invasive fungal disease in high-risk hematologic malignancies in children: a single-center experience

Garcia-Robles, AA; (...); Fernandez-Navarro, JM

Meeting Abstract. 2017

Bridges to pediatric stem cell transplant: a new lane through

Torres Guerola, Barbara, Carreno Sanchez, Sandra, Fernandez Navarro, Jose Maria

Meeting Abstract. 2018

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

Ladenstein, R; (...); SIOP Europe Neuroblastoma Group (SIOPEN)

Article. 10.1016/S1470-2045(17)30070-0. 2017

Cadmium (Cd) and Lead (Pb) topsoil levels and incidence of childhood leukemias

Asenjo S; (...); Ramis R

Article. 10.1007/s10653-021-01030-w. 2021

Calidad y Legibilidad de la Hoja de Informacion al Paciente en Estudios con Analisis Farmacogenetico.

Ruiz Ramos J; (...); Poveda Andrés JL

Article. 2015

Can We Identify Chemotherapy-Related Toxicity in Children with Cancer Through Automatized Integration of Healthcare Information Systems?

Berlanga, P; (...); Canete, A

Meeting Abstract. 2017

Cáncer en los primeros 18 meses de vida.

Urtasun Erburu A, Herrero Cervera MJ, Cañete Nieto A

Article. 10.1016/j.anpedi.2020.02.015. 2020

Cancer in children and adolescents in Spain: incidence, treatment setting and provider specialty

Berlanga, P.; (...); Castel, V.

Article. 10.1007/s12094-015-1330-y. 2016

Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities.

Velasco Puyó P; (...); Astigarraga I

Article. 10.1002/pbc.31120. 2024

Casuística de tumor miofibroblástico inflamatorio en centro terciario.

Martínez Navarro G; (...); Fernández Navarro JM

Case Reports. 10.1016/j.anpedi.2020.12.007. 2021

Casuistics of inflammatory myofibroblastic tumor in a tertiary center.

Martínez Navarro G; (...); Fernández Navarro JM

Case Reports. 10.1016/j.anpede.2020.12.016. 2021

Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience

Berlanga, P; (...); Ladenstein, R

Article. 10.1016/j.ejca.2020.10.020. 2021

CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study

Frezza, Anna Maria; (...); Gronchi, Alessandro

Article. 10.1002/cam4.5015. 2022

Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients

Article. 10.1016/j.thromres.2021.07.009. 2021

Clinical Characteristics and Management of Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: A Feasibility Analysis of Electronic Health Records Using Natural Language Processing.

Ortiz A; (...); Rodriguez M

Article. 10.1159/000528784. 2023

Clinical evaluation of rituximab treatment for neuromyelitis optica

Fernández-Megía MJ; (...); Poveda-Andrés JL

Article. 10.1016/j.nrl.2014.09.001. 2015

Clinical experience of whole body and tumour dosimetry of 131-I-mIBG treatment for pediatric patients

Espallardo, I. Torres; (...); Prado-Wohlwend, S.

Meeting Abstract. 2023

Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages.

J Ribelles A; (...); Castel V

Article. 10.1038/s41598-019-50327-5. 2019

Clinical guideline SEOM: hepatocellular carcinoma

Sastre J; (...); Feliu J

Article. 10.1007/s12094-015-1451-3. 2015

Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor Therapy

Maurel, J; (...); Montagut, C

Article. 10.1200/PO.18.00289. 2019

Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model

Nogueras, A; (...); Calleja, MA

Letter. 10.1136/ejhpharm-2019-001905. 2019

Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy

Labrador, J; (...); GATLA Grp

Article. 10.1080/10428194.2018.1522438. 2019

Clinicopathologic features and long-term follow-up of metastatic gastrointestinal stromal tumor (GIST) patients (pts) with durable response (> 5 years) to frontline imatinib (IM): A case-control study from GEIS

Serrano, C; (...); Broto, JM

Meeting Abstract. 2017

Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib

Serrano, C; (...); Carles, J

Article. 10.1634/theoncologist.2018-0032. 2019

Colestasis hepática infantil: presentación de un caso inusual de histiocitosis de células de Langerhans asociado a fibrosis avanzada.

Martínez I Cózar V; (...); Pérez Rojas J

Article. 10.1016/j.patol.2019.03.004. 2022

ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients

Vargas, T; (...); de Molina, AR

Article. 10.18632/oncotarget.3130. 2015

Collaborative model of home delivery program in haemophilia through an association of patients

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018

COMBINED RADIOLOGICAL, PATHOLOGICAL AND MOLECULAR OUTCOME EVALUATION IN NEWLY DIAGNOSED NON-BRAINSTEM PEDIATRIC HIGH-GRADE GLIOMA FROM THE RANDOMIZED, MULTICENTER HERBY PHASE II TRIAL

Jaspan, T; (...); Grill, J

Meeting Abstract. 2018

Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors

Berbegall, AP; (...); Noguera, R

Article. 10.1038/onc.2015.200. 2016

Comparative Multicentric Evaluation of Inter-Observer Variability in Manual and Automatic Segmentation of Neuroblastic Tumors in Magnetic Resonance Images

Veiga-Canuto, Diana; (...); Marti-Bonmati, Luis

Article. 10.3390/cancers14153648. 2022

Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo

Meeting Abstract. 2020

Complete response of a locally advanced basosquamous carcinoma with vismodegib treatment

Letter. 10.4103/ijdvl.IJDVL_647_18. 2019

Comprehensive detection of CRLF2 alterations in acute lymphoblastic leukemia: a rapid and accurate novel approach.

Gil, Jose Vicente; (...); Barragan, Eva

Article. 10.3389/fmolb.2024.1362081. 2024

Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

Campbell, K; (...); DuBois, SG

Article. 10.1002/pbc.27819. 2019

Concordance of baseline RAS mutational status (ms) between tissue and cell-free DNA (cfDNA) and association with overall response rate (ORR) in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study (cohort 2) (NCT02792478)

Valladares-Ayerbes, M; (...); Vila, AL

Meeting Abstract. 10.1016/j.annonc.2021.08.976. 2021

Congenital Critical Heart Defect Screening in a Health Area of the Community of Valencia (Spain): A Prospective Observational Study

Cubells, E; (...); Vento, M

Article. 10.3390/ijns4010003. 2018

Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain

Hidalgo, M; (...); Carrato, A

Article. 10.1007/s12094-016-1594-x. 2017

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023

Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.

González-Billalabeitia E; (...); Spanish Germ Cell Cancer Group and the Spanish Oncology Genitourinary Group

Article. 10.1016/j.euf.2016.07.002. 2017

Consensus SEO-SEFH of recommendations for use and compounding of ophthalmic preparations.

Fuentes-Irigoyen, R; (...); Yañez Martínez JR

Article. 10.7399/fh.10943. 2018

Controversies in the multimodality management of locally advanced rectal cancer

Díaz Beveridge R; (...); Aparicio, J

Review. 10.1007/s12032-017-0964-8. 2017

Correction to: Recommendations for follow-up of colorectal cancer survivors.

Vera R; (...); Fernández-Cebrián JM

Article. 10.1007/s12094-019-02088-w. 2019

Correction: Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study.

de Beijer IAE; (...); Pluijm SMF

Correction. 10.1007/s11764-024-01547-w. 2024

Correction: Update on the management of elderly patients with colorectal cancer.

Soler-González G; (...); Gironés-Sarrió R

Correction. 10.1007/s12094-023-03351-x. 2024

Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer

Feliu, J; (...); Maurel, J

Article. 10.1371/journal.pone.0116527. 2015

Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study

Vera, R; (...); Viudez, A

Article. 10.3390/cancers12082259. 2020

COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA

Gironella, M.; (...); Oyaguez, I

Meeting Abstract. 2019

COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN

Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.

Meeting Abstract. 2024

Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1080/13696998.2017.1311903. 2017

Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.

Poveda JL; (...); Torres C

Article. 10.1080/14737167.2019.1635014. 2020

COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN

Trillo, JL; (...); Torres, C

Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018

Cost-effectiveness of methoxy polyethylene glycolepoetin beta versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice

Lorente-Fernandez, L; (...); Poveda-Andres, JL

Article. 10.1136/ejhpharm-2013-000426. 2015

COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN

Bonanad, S; (...); Gonzalez-Dominguez, A

Meeting Abstract. 2020

Costs of the management of hemophilia A with inhibitors in Spain

Bonanad, S; (...); Gonzalez-Dominguez, A

Article. 10.33393/grhta.2021.2234. 2021

Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis

Letter. 10.1111/hae.13733. 2019

Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Eduardo Megias, Juan; (...); Iorio, Alfonso

Meeting Abstract. 10.1182/blood-2019-127946. 2019

Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group

Fernández-Bañares F; (...); Gisbert JP

Article. 10.1111/apt.13477. 2016

Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP).

Gargallo, P.; (...); Moreno, L.

Article. 10.1007/s12094-021-02759-7. 2022

Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.

Garrido-Jareño M; (...); Pemán-García J

Article. 10.1186/s13071-020-3901-1. 2020

Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.

Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL

Editorial Material. 10.1016/j.farma.2024.08.001. 2024

Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP).

Rubio-San-Simon, A.; (...); Bautista, F.

Article. 10.1007/s12094-020-02399-3. 2021

Characteristics and outcomes of advanced melanoma patients with complete response and elective discontinuation of first-line anti-programmed death-1 monotherapy: A real-world multicentre observational cohort study.

Ochenduszko, Sebastian; (...); Maiques, Inmaculada Maestu

Article. 10.1111/pcmr.13093. 2023

Characterization of Pediatric Acute Myeloid Leukemia With t(7;12)(q36;p13)

Ostlund, Anders; (...); Palmqvist, Lars

Article. 10.1002/gcc.70003. 2024

Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial

Fernandez-Martos C; (...); Minsky BD

Article. 10.1093/annonc/mdv223. 2015

Childhood and Adolescent Central Nervous System Tumours in Spain: Incidence and Survival over 20 Years: A Historical Baseline for Current Assessment.

Chirlaque MD; (...); The Spanish Childhood Cancer Epidemiology Working Group

Article. 10.3390/cancers15245889. 2023

Chip-AML22 Master Protocol: An Open-Label Clinical Trial in Newly Diagnosed Pediatric De Novo Acute Myeloid Leukemia (AML) Patients Including a Linked Phase II Trial with Quizartinib in FLT3-ITD/ NPM1wt Patients - a Study By the NOPHO-DB-SHIP Consortium

Kaspers, Gertjan J. L.; (...); Pronk, Cornelis Jan

Meeting Abstract. 10.1182/blood-2023-181792. 2023

Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.1080/17512433.2019.1573668. 2019

Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders.

Salmeron-Villalobos, Julia; (...); Salaverria, Itziar

Article. 10.1182/blood.2022019543. 2023

Defibrotide in Hematopoietic Stem Cell Transplant: An Study of Grupo Espanol De Trasplante Hematopoyetico (GETH) And Grupo Espanol De Trasplante De Medula En NinOS (GETMON)

Vicent, MG; (...); Diaz, MA

Meeting Abstract. 2020

Defibrotide In Hematopoietic Stem Cell Transplantation: A Multicenter Survey Study Of The Spanish Hematopoietic Stem Cell Transplantation Group (Geth).

González Vicent M; (...); Díaz MÁ

Article. 10.1111/ejh.13618. 2021

Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project

Blade, J; (...); Lizan, L

Article. 10.1136/bmjopen-2017-018850. 2018

Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition

Sanmartin, E; (...); Font de Mora J

Article. 10.1158/1078-0432.CCR-17-0593. 2017

Delving into the clinical impact of NETs in pediatric cancer.

Benavent N; (...); Medina P

Article. 10.1038/s41390-024-03437-4. 2024

DESCRIPTION OF THE CYTOOGENETIC ANOMALIES OF A SERIES OF PATIENTS OF THE SEHOP-PETHEMA 2013 PEDIATRIC PROTOCOL FOR THE TREATMENT OF B-LINE

Hidalgo Gomez, G.; (...); Ortega, M.

Meeting Abstract. 2018

Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.

Salinas P; (...); Escaned J

Article. 10.1016/j.carrev.2021.11.015. 2021

Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

Alvarez-Roman, MT; (...); Badia, X

Article. 10.1177/2284240319880534. 2019

DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)

Alvarez, E.; (...); Badia, F. J.

Meeting Abstract. 2019

Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024

Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024

DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN

Poveda, J. L.; (...); Vitoria, I

Meeting Abstract. 2019

Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain

Badia, X; (...); Poved, JL

Article. 10.1080/21678707.2019.1652163. 2019

Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning.

Munoz, Andres J.; (...); Hernandez-Presa, Miguel Angel

Article. 10.1016/j.thromres.2023.06.015. 2023

Development of Hepatoblastoma organoids as a patient-derived ex-vivo system

Zanatto, Laura; (...); Sancho-Bru, Pau

Meeting Abstract. 2022

Development of the ECLIM-SEHOP Clinical Trial Platform: Implementing International Academic Clinical Trials for Childhood Cancer and Blood Disorders in Spain

Fernandez-Teijeiro, A; (...); Moreno, L

Meeting Abstract. 2020

Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital.

Simarro J; (...); Palanca S

Article. 10.3390/cancers11081196. 2019

Dexamethasone does not prevent malignant cell reintroduction in leukemia patients undergoing ovarian transplant: risk assessment of leukemic cell transmission by a xenograft model

Diaz-Garcia, C; (...); Pellicer, A

Article. 10.1093/humrep/dez115. 2019

Distribution of segmental chromosomal alterations in neuroblastoma.

Juan Ribelles A; (...); Castel V

Article. 10.1007/s12094-020-02497-2. 2020

Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma

Salmeron-Villalobos, Julia; (...); Salaverria, Itziar

Article. 10.1002/pbc.29926. 2022

Dose banding aplicado a la elaboracion de antineoplasicos: una revision narrativa de la literatura.

Pérez Huertas P; (...); Poveda Andrés JL

Article. 10.7399/fh.2015.39.4.8839. 2015

Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?

Contreras-Toledo, Debora; (...); Carmona-Bayonas, Alberto

Article. 10.1038/s41416-023-02563-w. 2024

Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial

Pineda, E; (...); Maurel, J

Article. 10.1177/1010428317705509. 2017

Early clinical trials in paediatric oncology in Spain: a nationwide perspective

Bautista, F; (...); Sociedad Española de Hematología y Oncología Pediátrica (SEHOP) and the New Drug

Article. 10.1016/j.anpedi.2016.07.007. 2017

Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases

Review. 10.1007/s10072-017-2833-9. 2017

ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain.

Bautista, F; (...); Sociedad Española de Hematología y Oncología Pediátrica (SEHOP)

Article. 10.1007/s12094-019-02221-9. 2019

ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer.

Juan-Ribelles A; (...); Fernández-Teijeiro A

Article. 10.1007/s12094-024-03445-0. 2024

Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan

Ribera, E; (...); Hernandez-Novoa, B

Article. 10.1016/j.eimc.2016.11.015. 2018

Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.

Torres Martínez E; (...); Vento M

Article. 10.1016/j.anpedi.2020.03.009. 2020

Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies

Rojas L; (...); Aliño SF

Article. 10.1038/tpj.2014.38. 2015

Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment

Palanques-Pastor T; (...); Poveda Andrés JL

Article. 10.1159/000517813. 2021

Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma

Ballester-Sánchez R; (...); Perez-Calatayud J

Article. 10.5114/jcb.2015.52140. 2015

El nuevo reto en oncologia: la secuenciacion NGS y su aplicacion a la medicina de precision.

Calabria I; (...); Castel V

Article. 10.1016/j.anpedi.2016.05.006. 2016

eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Megias-Vericat, JE

Meeting Abstract. 2018

Encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma, real-world evidence in Spain (GEM 2002-BECARE)

Soria, A.; (...); Cerezuela-Fuentes, P.

Meeting Abstract. 10.1016/j.annonc.2023.09.2248. 2023

Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study).

Marquez-Rodas, Ivan; (...); Berrocal, Alfonso

Article. 10.1093/neuonc/noae116. 2024

Endocrinological late effects of oncologic treatment on survivors of medulloblastoma

Santos, ADH; (...); Nieto, AC

Article. 10.32641/rchped.v90i6.994. 2019

Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications

Carrillo-Reixach, J; (...); Armengol, C

Article. 10.1016/j.jhep.2020.03.025. 2020

Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies

Carreño M; (...); Graus, F

Article. 10.1016/j.eplepsyres.2016.12.010. 2017

Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions

Salvador, J; (...); Garrido, P

Article. 10.1007/s12094-016-1535-8. 2017

Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions (vol 19, pg 341, 2017)

Salvador J; (...); Garrido P

Correction. 10.1007/s12094-017-1628-z. 2017

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

Honecker, F; (...); Horwich, A

Article. 10.1093/annonc/mdy217. 2018

Estado actual de la criopreservación de la fertilidad en varones prepúberes.

Medrano JV; (...); Pellicer A

Review. 10.1016/j.androl.2018.07.006. 2020

European Association of Urology (EAU) Testicular Cancer Guidelines Panel: A new prognostic factor risk group classification for patients with clinical stage 1 seminoma in active surveillance.

Boormans, Joost; (...); Laguna, Pilar

Meeting Abstract. 2023

EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN

Badia, F. J.; (...); Shepherd, J.

Meeting Abstract. 2019

Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas

Trinidad, Eva Maria; (...); de Mora, Jaime Font

Article. 10.3389/fonc.2023.1037342. 2023

EVALUATION OF THE IMPLEMENTATION OF THE RANO CRITERIA IN THE HERBY TRIAL OF PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMAS

Rodriguez, D; (...); Jaspan, T

Meeting Abstract. 2018

Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis

Corrias, MV; (...); Burchill, SA

Article. 10.1002/pbc.27052. 2018

Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study.

Valladares-Ayerbes M; (...); Lloansí Vila A

Article. 10.3390/cancers14246075. 2022

Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI.

Garcia-Vidal, C; (...); Cuenca-Estrella, M

Article. 10.1016/j.eimc.2018.03.018. 2019

Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study.

Morini M; (...); Varesio L

Article. 10.3390/cancers11101476. 2019

Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors

Ruiz Ramos J; (...); Poveda Andrés JL

Article. 10.1016/j.gastrohep.2014.05.004. 2014

Experience of Home Delivery Program in Haemophilia Through an Association of Patients

Megias Vericat, J. E.; (...); Bonanad Boix, S.

Meeting Abstract. 2017

Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia.

Galán Gómez V; (...); Pérez-Martínez A

Article. 10.1016/j.anpede.2021.02.016. 2022

Experiencia del Grupo Español de Trasplante Hematopoyético (GETMON-GETH) en el trasplante alogénico de progenitores hematopoyéticos en leucemia aguda linfoblástica Philadelphia.

Galán Gómez V; (...); Pérez-Martínez A

Article. 10.1016/j.anpedi.2021.02.015. 2021

EXPERTS CONSENSUS ON THE FUTURE OF RARE DISEASES CARE AND ORPHAN DRUGS ACCESS IN SPAIN: A DELPHI STUDY

Paz S; (...); Urcelay J

Meeting Abstract. 10.1016/j.jval.2015.09.2016. 2015

Exploratory analysis for the implementation of antineoplastic logarithmic dose banding

Albert-Mari, A; (...); Poveda-Andres, JL

Article. 10.1007/s11096-018-0714-9. 2018

EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY

F, de Andres-Nogales; (...); Martinez, M.

Meeting Abstract. 2019

Feasibility and Safety of a Modified Outpatient Regimen With Intravenous/Intraperitoneal Chemotherapy for Optimally Debulked Stage III Ovarian Cancer

Bruixola G; (...); Santaballa A

Article. 10.1097/IGC.0000000000000330. 2015

Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease

Beltran, B; (...); Nos, P

Article. 10.1159/000492626. 2019

Fertility preservation in boys: recent developments and new insights † .

Goossens E; (...); Stukenborg JB

Article. 10.1093/hropen/hoaa016. 2020

Fertility preservation in children/adolescent patient with cancer

Moreno, M. Andres, Sanchez, H. Martinez, Macian, F. Moreno

Article. 10.1016/j.gine.2024.100966. 2024

Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report

Fernandez-Sanchez, M; (...); Poveda-Andres, JL

Article. 10.1002/bdr2.1942. 2021

First in human trial of CEB-01 for retroperitoneal soft tissue sarcoma

Gonzalez, J. A.; (...); Lopez Pousa, A.

Meeting Abstract. 10.1016/j.annonc.2023.09.1161. 2023

First-in-human CEB-01: Novel loco-regional SN-38 release membrane to prevent local recurrence in retroperitoneal sarcomas

Gonzalez-Lopez, Jose Antonio; (...); Pousa, Antonio Lopez

Meeting Abstract. https://doi.org/10.1016/j.annonc.2023.09.1161. 2024

First-line chemotherapy with or without targeted therapies in metastatic colorectal cancer: The GEMCAD 14-01 prospective cohort

Oliveres, H.; (...); Maurel, J.

Meeting Abstract. 10.1016/j.annonc.2023.09.1796. 2023

First-line treatment with panitumumab plus FOLFIRI in elderly patients with RAS/BRAF wild-type unresectable metastatic colorectal cancer and good performance status: OPALO trial.

Feliu, Jaime; (...); Aparicio, Jorge

Meeting Abstract. 10.1200/JCO.2018.36.15_suppl.TPS3618. 2018

Folliculocystic and collagenous hamartoma of tuberous sclerosis complex, not always a single cutaneous lesion.

Roca-Ginés J; (...); Évole-Buselli M

Article. 10.1111/pde.14310. 2020

Free flaps as a first option for reconstruction of shoulder girdle high recurrence risk tumors.

Pérez-García A; (...); Baixauli F

Letter. 10.1002/jso.26064. 2020

Gangliogliomas in the pediatric population.

Quiroz Tejada AR; (...); Botella-Asunción C

Article. 10.1007/s00381-020-04900-3. 2020

GAP IN SECONDARY FRACTURE PREVENTION (BUT NOT IN PRIMARY PREVENTION OF INFECTION AND THROMBOSIS) FOLLOWING A HIP FRACTURE: THE SPARE-HIP PROSPECTIVE COHORT

Prieto-Alhambra, D; (...); Diez-Perez, A

Meeting Abstract. 2017

Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)

Martin-Broto, J; (...); Lopez-Pousa, A

Article. 10.1093/annonc/mdx536. 2017

Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024

Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care.

Gargallo P; (...); Cañete A

Article. 10.3390/cancers13215339. 2021

Germline variant in Ctcf links mental retardation to Wilms tumor predisposition

Gargallo, Pablo; (...); Font de Mora, Jaime

Article. 10.1038/s41431-022-01105-x. 2022

Global Retinoblastoma Presentation and Analysis by National Income Level.

Global Retinoblastoma Study Group; (...); Bowman R

Article. 10.1001/jamaoncol.2019.6716. 2020

Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis

Poveda Andres, Jose Luis

Editorial Material. 2022

Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12568. 2017

Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH).

Pérez-Martínez A; (...); Díaz MÁ

Article. 10.1002/ajh.25661. 2020

Haploidentical versus Cord Blood transplantation in pediatric AML. A retrospective outcome analysis on behalf of the pediatric subcommittee of GETH (Grupo Español de Trasplante Hematopoyético).

Sisinni L; (...); de Heredia CD

Article. 10.1016/j.jtct.2024.07.013. 2024

Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet).

Moreno, Celia; (...); Fuster, Jose Luis

Article. 10.3389/fped.2023.1140637. 2023

Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study

Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units

Article. 10.7399/fh.10935. 2018

Hazardous drugs: new challenges, new opportunities.

Valero García S; (...); Poveda Andrés JL

Article. 10.7399/fh.2016.40.2.10462. 2016

Headache, hypertension and seizures

Arcos-Machancoses, JV; (...); Verdeguer-Miralles, A

Editorial Material. 10.1111/jpc.12596. 2015

Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Solana-Altabella, Antonio; (...); Martinez-Cuadron, David

Article. 10.3390/cancers14081921. 2022

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia.

Vega-Garcia N; (...); Camós M

Article. 10.3390/jpm10040244. 2020

Hematopoietic stem cell transplantation in children with chronic granulomatous disease: the Spanish experience.

Alonso García L; (...); Diaz de Heredia Rubio C

Article. 10.3389/fimmu.2024.1307932. 2024

High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.

El-Qutob D; (...); Carrera-Hueso FJ

Article. 10.1016/j.hrtlng.2022.02.003. 2022

High Oct4 expression: implications in the pathogenesis of neuroblastic tumours

Monferrer, E; (...); Noguera, R

Article. 10.1186/s12885-018-5219-3. 2019

HIGH RISK NEUROBLASTOMA (HR-NB) WITH MNA AND AGE

Ladenstein, Ruth; (...); Canete, Adela

Meeting Abstract. 2023

High risk neuroblastoma (HR-NB) with MNA and age <18 months: Results from the HR-NBL1/SIOPEN trial

Ladenstein, Ruth Lydia; (...); Canete, Adela

Meeting Abstract. 2023

High-permeability region size on perfusion CT predicts hemorrhagic transformation after intravenous thrombolysis in stroke

Puig, J; (...); Castellanos, M

Article. 10.1371/journal.pone.0188238. 2017

High-risk neuroblastoma: where do we go?

Cañete A

Editorial Material. 10.1016/j.annonc.2019.12.003. 2020

Histologic Analysis of Testes from Prepubertal Patients Treated with Chemotherapy Associates Impaired Germ Cell Counts with Cumulative Doses of Cyclophosphamide, Ifosfamide, Cytarabine, and Asparaginase.

Medrano, V, Jose; (...); Novella-Maestre, E.

Article. 10.1007/s43032-020-00357-6. 2021

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Gronchi A; (...); Casali PG

Article. 10.1016/S1470-2045(17)30334-0. 2017

HLA-haploidentical transplantation in children: a retrospective analysis of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON-GETH)

Pascual, A; (...); Diaz, MA

Meeting Abstract. 2018

Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies

Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo

Article. 10.7399/fh.11729. 2022

Hospitalization budget impact during the COVID-19 pandemic in Spain.

Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.

Article. 10.1186/s13561-021-00340-0. 2021

How can artificial intelligence optimize value-based contracting?

Poveda, Jose Luis; (...); Medrano, Ignacio H.

Letter. 10.1186/s40545-022-00475-3. 2022

Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)

Seidel, C; (...); Bokemeyer, C

Article. 10.1016/j.ejca.2020.03.022. 2020

Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.

Rodríguez-Lescure Á; (...); de la Haba-Rodriguez J

Article. 10.1007/s12094-024-03411-w. 2024

Identification Of Actionable Genetic Targets In Primary Cardiac Sarcomas

Salvador-Coloma, C; (...); de Mora, JF

Article. 10.2147/OTT.S214319. 2019

Immunoproteomic studies on paediatric opsoclonus-myoclonus associated with neuroblastoma

Torres-Vega E; (...); Bataller L

Article. 10.1016/j.jneuroim.2016.05.015. 2016

ImmunoSarc2: A Spanish Sarcoma Group (GEIS) phase Ib trial of doxorubicin and dacarbazine plus nivolumab in first line treatment of advanced leiomyosarcoma

Martin Broto, Javier; (...); Hindi, Nadia

Meeting Abstract. 2023

Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2016.1231405. 2017

Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart (R) in patients with multiple sclerosis

Edo Solsona MD; (...); Poveda Andrés JL

Article. 10.2147/PPA.S127508. 2017

IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART (R) IN PATIENTS WITH MULTIPLE SCLEROSIS

Edo-Solsona, M.; (...); Poveda-Andres, J.

Meeting Abstract. 10.1016/j.jval.2016.09.512. 2016

Impact of an antimicrobial stewardship program on critical haematological patients.

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.7399/fh.2017.41.4.10709. 2017

Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1080/10428194.2020.1839650. 2020

Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium.

Rubio-San-Simón A; (...); Bautista F

Article. 10.1016/j.ejca.2020.09.024. 2020

Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1038/tpj.2017.19. 2018

Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1097/FPC.0000000000000286. 2017

Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation

Ruiz J; (...); Aliño SF

Article. 10.3390/ijms160920168. 2015

Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Badia X; (...); Hernández C

Article. 10.1186/s13023-020-01507-4. 2020

Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia

Meeting Abstract. 2015

Impact of voriconazole plasma concentrations on treatment response in critically ill patients

Ruiz, J; (...); Ramirez, P

Article. 10.1111/jcpt.12817. 2019

Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases

Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL

Article. 10.7399/fh.11262. 2020

Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1159/000478969. 2018

Independent Validation of a Deep Learning nnU-Net Tool for Neuroblastoma Detection and Segmentation in MR Images

Veiga-Canuto, Diana; (...); Marti-Bonmati, Luis

Article. 10.3390/cancers15051622. 2023

Indeterminate Cell Histiocytosis in Children: A Case Report.

Sahuquillo-Torralba, A.; (...); Botella-Estrada, R.

Letter. 10.1016/j.ad.2017.01.022. 2017

Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Vericat, JEM; (...); Bonanad, S

Meeting Abstract. 2018

Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Megias-Vericat, Juan Eduardo; (...); Bonanad, Santiago

Meeting Abstract. 10.1182/blood.V128.22.3802.3802. 2016

Infectious Diseases Working Party Retrospective Study on HHV-6 encephalitis: clinical characteristics and outcome after allogeneic HSCT

Ward, KN; (...); Styczynski, J

Meeting Abstract. 2018

Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies

Megías-Vericat JE; (...); Aliño SF

Review. 10.1038/tpj.2014.80. 2015

Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy

Bastida, G; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019

Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2017.1323267. 2017

Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.

Ruiz J; (...); Poveda JL

Article. 10.23736/S0026-4946.18.04978-2. 2018

Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1097/FPC.0000000000000431. 2021

Influence of Sex on Gestational Complications, Fetal-to-Neonatal Transition, and Postnatal Adaptation

Lorente-Pozo, Sheila; (...); Vento, Maximo

Review. 10.3389/fped.2018.00063. 2018

Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia

Meeting Abstract. 2015

Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic

Faura, A; (...); Dapena, JL

Letter. 10.1002/pbc.28557. 2020

Interdisciplinary recommendations document to improve adherence in patients with chronic inflammatory diseases: Adhing recommendations.

Bermejo San José F; (...); Sanromán-Álvarez L

Article. 10.7399/fh.2016.40.5.10180. 2016

Interim analysis of a phase II study of nivolumab combined with ipilimumab in patients with pediatric solid tumors in adulthood (GETHI021).

Mielgo, X; (...); Garcia-Donas, J

Meeting Abstract. 10.1200/JCO.2019.37.15_suppl.2613. 2019

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.

Gonzalez-Cao M; (...); Berrocal A

Article. 10.1038/s41467-021-26572-6. 2021

International benchmarking of childhood cancer survival by tumour stage: First results of the BENCHISTA project

Pritchard-Jones, K.; (...); Gatta, G.

Meeting Abstract. 2024

International benchmarking of stage at diagnosis for six childhood solid tumours (the BENCHISTA project): a population-based, retrospective cohort study.

Botta, Laura; (...); Pritchard-Jones, Kathy

Article. 10.1016/S2352-4642(24)00302-X. 2025

Interoperability Architecture for a Paediatric Oncology European Reference Network.

Nitzlnader, M; (...); Schreier, G

Article. 10.3233/978-1-61499-645-3-39. 2016

Intracranial activity of encorafenib and binimetinib followed by radiotherapy in patients with BRAF mutated melanoma and brain metastasis: Preliminary results of the GEM1802/EBRAIN-MEL phase II clinical trial

Marquez-Rodas, I; (...); Berrocal, A

Meeting Abstract. 10.1016/j.annonc.2021.08.1423. 2021

Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12842. 2019

Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targets.

Coronado, Esther; (...); Font de Mora, Jaime

Article. 10.1002/1878-0261.12868. 2021

Intravascular Biphasic Synovial Sarcoma: The Beneficial Role of Adjuvant Treatment Approach in the Pre-metastatic Stage.

Chicas-Sett R; (...); Tormo A

Article. 10.7759/cureus.572. 2016

Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.

Solana-Altabella A; (...); Poveda JL

Article. 10.1177/1078155220904410. 2020

Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19

Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP

Article. 10.1136/ejhpharm-2020-002322. 2020

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024

Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.

Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula

Article. 10.3390/antibiotics13080706. 2024

IT-Related Barriers and Facilitators to the Implementation of a New European eHealth Solution, the Digital Survivorship Passport (SurPass Version 2.0): Semistructured Digital Survey.

de Beijer, Ismay A E; (...); Chronaki, Catherine

Article. 10.2196/49910. 2024

Lack of TERT promoter mutations in melanomas with extensive regression

De Unamuno Bustos B; (...); Botella Estrada R

Letter. 10.1016/j.jaad.2015.10.003. 2016

Landscape of early clinical trials for childhood and adolescence cancer in Spain

Bautista F; (...); Moreno L

Article. 10.1007/s12094-015-1421-9. 2016

Langerhans cell histiocytosis of the head and neck in the pediatric population in a tertiary center: Clinical presentation, classification and treatment.

García Díaz MP; (...); Carceller, Miguel Armengot

Article. 10.1016/j.ijporl.2022.111073. 2022

Large B-cell Lymphomas in Pediatric and Young Adult Population Are Genetically Heterogeneous

Gonzalez-Farre, B; (...); Salaverria, I

Meeting Abstract. 2017

Large B-cell Lymphomas in Pediatric and Young Adult Population Are Genetically Heterogeneous

Gonzalez-Farre, B; (...); Salaverria, I

Meeting Abstract. 2017

Lateral-type posterior fossa ependymomas in pediatric population

Miranda-Lloret, Pablo; (...); Llavador, Gemma

Article. 10.1016/j.neucir.2023.10.002. 2024

Lateral-type posterior fossa ependymomas in pediatric population.

Miranda-Lloret, Pablo; (...); Llavador, Gemma

Article. 10.1016/j.neucie.2023.10.001. 2024

Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050) : a multicentre, open-label, multicohort, phase 1/2 study

Gaspar, N; (...); Campbell-Hewson, Q

Article. 10.1016/S1470-2045(21)00387-9. 2021

Li-Fraumeni syndrome heterogeneity.

Gargallo P; (...); Cañete A

Review. 10.1007/s12094-019-02236-2. 2020

Li-Fraumeni: Will the detection in families increase the survival of its members?

Gargallo, P; (...); Canete, A

Letter. 10.1016/j.anpedi.2018.03.009. 2019

Linfadenopatias gigantes de curso benigno: enfermedad de Rosai-Dorfman.

Pemartin B; (...); Ferrer B

Article. 10.1016/j.anpedi.2014.02.001. 2014

Liquid Biopsies of Patients with HIGH-RISK Neuroblastoma Disclose Exosomal miRNA Modulation after the Induction Therapy

Morini, M; (...); Varesio, L

Meeting Abstract. 2017

Liquid Biopsies Provide Exosomal MicroRNAs as Biomarkers of the Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients

Morini, M; (...); Varesio, L

Meeting Abstract. 2018

Liquid Biopsy Micro-RNA Profiling in Meduloblastoma

Yanez, Y; (...); Canete, A

Meeting Abstract. 2018

Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA.

Trinidad EM; (...); Font de Mora J

Article. 10.1093/bib/bbac575. 2023

Long-Term Results for Infants with Neuroblastoma Treated Between 2000 and 2D004 According to INES Protocols -INESFU- A SIOPEN Study

Munzer, C; (...); Gambart, M

Meeting Abstract. 2019

Lymph microvascularization as a prognostic indicator in neuroblastoma.

Tadeo I; (...); Noguera R

Article. 10.18632/oncotarget.25457. 2018

Maintenance of angiogenesis inhibition with aflibercept after progression to bevacizumab in metastatic colorectal cancer: real life study in the Valencian community.

Raga, Mireia Gil; (...); Hernandez, Isabel Busquier

Article. 10.1007/s12094-022-03047-8. 2023

Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care

de Rojas, T; (...); Moreno, L

Article. 10.1007/s11060-017-2713-4. 2018

Management and supportive treatment of frail patients with metastatic pancreatic cancer

Macarulla, T; (...); Hidalgo, M

Review. 10.1016/j.jgo.2018.06.005. 2019

Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.

Megías-Vericat JE; (...); Poveda-Andrés JL

Article. 2021

Management of Hyperleukocytosis in Pediatric Acute Myeloid Leukemia Using Immediate Chemotherapy without Leukapheresis, in Protocol NOPHO-DBH AML-2012

Zeller, Bernward; (...); Abrahamsson, Jonas

Meeting Abstract. 10.1182/blood-2023-184921. 2023

Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 Protocol.

Zeller B; (...); Abrahamsson J

Article. 10.3324/haematol.2024.285285. 2024

Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience.

Guerra-García P; (...); Taj MM

Article. 10.1002/pbc.31053. 2024

Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.

Vázquez Polo A; (...); Vázquez Costa JF

Article. 10.20960/nh.03946. 2022

Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A

Bonanad, S; (...); Santos, S

Article. 10.1007/s12325-021-01853-0. 2021

Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group.

van Weelderen, Romy E; (...); Kaspers GJL

Article. 10.1200/JCO.22.02120. 2023

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.

Vega-García N; (...); Camós M

Article. 10.3389/fped.2020.614521. 2021

Medulloblastoma: improved survival in recent decades. Unicentric experience

Igual Estellés L, Berlanga Charriel P, Cañete Nieto A

Article. 10.1016/j.anpedi.2016.03.004. 2017

Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Article. 10.3390/cancers14030596. 2022

Metabolomic profiling in neuroblastoma.

Quintás G; (...); Segura V

Article. 10.1002/pbc.28113. 2020

Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease.

Aparicio J; (...); Fernandez-Montes A

Review. 10.3390/jcm9123889. 2020

Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?

Di Cataldo, A; (...); Canete, A

Article. 10.1007/s12094-016-1505-1. 2017

Methodological advances in the discovery of novel neuroblastoma therapeutics.

Segura MF; (...); Moreno L

Article. 10.1080/17460441.2022.2002297. 2022

Metyrapone as treatment in the neonatal McCune-Albright syndrome

de Mingo, Carmen; (...); Garcia-Robles, Ana

Article. 10.1515/jpem-2020-0036. 2020

miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis

Berlanga P; (...); Font de Mora J

Article. 10.1016/j.molonc.2016.04.004. 2016

Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease.

Tierens, Anne; (...); Abrahamsson, Jonas

Article. 10.1200/JCO.23.01841. 2024

Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs.

Reinal, Ignacio; (...); Sepulveda, Pilar

Article. 10.3390/antiox12071378. 2023

Monitoring coagulation factors during surgery. A systematic review

Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11766. 2021

Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).

Valero-García S; (...); Delgado-Sánchez O

Article. 10.7399/fh.11655. 2021

Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.

Fernandez-Megia, MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.10793. 2018

Monosegment ALPPS: A new variant of the techniques for rapid hepatic regeneration. Critical review of the initial results of our series

Montalvá Orón EM; (...); López-Andújar R

Article. 10.1016/j.ciresp.2015.02.011. 2015

MR Denoising Increases Radiomic Biomarker Precision and Reproducibility in Oncologic Imaging

Fernández Patón M; (...); Martí-Bonmatí L

Article. 10.1007/s10278-021-00512-8. 2021

MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II Trial.

Rodriguez D; (...); Jaspan T

Article. 10.1148/radiol.211464. 2022

MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients

Olivera, GG; (...); Herrero, MJ

Article. 10.3390/ijms21082714. 2020

Multicenter real-world data of treatment with NALIRI plus 5FU/LV in advanced Spanish pancreatic cancer

Alvarez Gallego, R.; (...); Cubillo, A.

Meeting Abstract. 10.1016/j.annonc.2023.04.238. 2023

Multimodality Treatment of Pediatric and Adult Patients With Ewing Sarcoma: A Single-institution Experience

Diaz-Beveridge, R; (...); JORGE APARICIO URTASUN

Article. 10.1097/MPH.0000000000000339. 2015

Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments

Gomez-Cebrian, N; (...); Pineda-Lucena, A

Review. 10.3390/cancers13184544. 2021

N. VICTOR JIMENEZ TORRES (1942-2015) IN MEMORIAM

Climente Martí M, Poveda Andrés JL, Culebras J

Biographical-Item. 10.3305/nh.2015.32.4.9704. 2015

National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)

Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel

Correction. 10.7399/fh.11740. 2021

National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022

Nefroblastoma. Experiencia a largo plazo en el abordaje multidisciplinario.

Rodriguez Iglesias P; (...); Boronat Tormo F

Abstract of Published Item. 2018

Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).

Gronchi, Alessandro; (...); Casali, Paolo Giovanni

Article. 10.1200/JCO.23.00908. 2024

Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.

Pasquali, Sandro; (...); Gronchi, Alessandro

Article. 10.1002/cncr.33895. 2022

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups

Gronchi, A; (...); Casali, PG

Article. 10.1200/JCO.19.03289. 2020

Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Results of the expanded cohort of myxoid liposarcoma of the randomized clinical trial from the Italian Sarcoma Group (ISG), the Spanish Sarcoma Group (GEIS), the French Sarcoma Group (FSG), and the Polish Sarcoma Group (PSG).

Gronchi, Alessandro; (...); Casali, Paolo Giovanni

Meeting Abstract. 2022

Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma

Alvarez, R; (...); Hidalgo, M

Review. 10.1007/s12094-017-1680-8. 2017

Neonatal Suprarenal Masses: An Observational Approach

Papadakis, V; (...); Canete, A

Meeting Abstract. 2018

Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries - A study by the Joint Action on Rare Cancers.

Cañete A; (...); Spanish Neuroblastoma Linkage Working Group (SpNbLinkWG)

Article. 10.1016/j.canep.2022.102145. 2022

New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024

Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas

Ribelles, AJ; (...); Canete, A

Article. 10.3390/jpm11040268. 2021

Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023

Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023

Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Poveda, JL

Meeting Abstract. 2018

Optimising Urinary Catecholamine Diagnostics for Neuroblastoma Patients

Matser, Y; (...); Tytgat, G

Meeting Abstract. 2020

Optimized Cytogenetic Risk-Group Stratification of KMT2A-Rearranged Pediatric Acute Myeloid Leukemia.

van Weelderen, Romy E.; (...); Kaspers, Gertjan J. L.

Article. 10.1182/bloodadvances.2023011771. 2024

OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT

Flores-Moreno, S.; (...); Gil, A.

Meeting Abstract. 2024

Outcome after HSCT in Children with JMML from a Historical Point of View

Duarte, ML; (...); Vazquez, GP

Meeting Abstract. 2020

OUTCOME OF BRAF V600E PEDIATRIC GLIOMAS TREATED WITH TARGETED BRAF INHIBITION

Nobre, L; (...); Tabori, U

Meeting Abstract. 2020

Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma

Fischer, S; (...); Gillessen, S

Article. 10.1200/JCO.2016.69.0958. 2017

Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma.

Fischer, Stefanie Christine; (...); Gillessen, Silke

Meeting Abstract. 10.1200/JCO.2019.37.7_suppl.510. 2019

Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.

Fischer S; (...); Global Germ-Cell Cancer Group

Article. 10.1200/JCO.19.01876. 2020

Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)

Maurel, J; (...); Fernandez-Cruz, L

Article. 10.1007/s00280-018-3682-9. 2018

Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition.

Nobre L; (...); Tabori U

Article. 10.1200/PO.19.00298. 2020

Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia

Ruggeri, A; (...); Corbacioglu, S

Article. 10.1016/j.jtct.2021.01.016. 2021

Ovarian transposition as a minimally invasive fertility preservation technique: ten years of experience in a pediatric center.

Costa-Roig A; (...); Vila Carbó J

Article. 2020

Paediatric tumour boards in Spain: a national survey

Berlanga, P; (...); Canete, A

Article. 10.1007/s12094-015-1466-9. 2016

Pancreatic cancer, Radiomics and Artificial Intelligence: A Review.

Marti-Bonmati L; (...); Alberich-Bayarri A

Article. 10.1259/bjr.20220072. 2022

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Garcia-Robles, Ana; (...); Carrascosa, MA

Article. 10.3389/fped.2020.00372. 2020

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Correction. 10.3389/fped.2021.834454. 2022

Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project

Morillo-Verdugo, R; (...); Diaz-Olmo, J

Article. 10.7399/fh.11719. 2021

Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.

Morillo-Verdugo R; (...); Díaz-Olmo J

Article. 2021

Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.

Vo, Kieuhoa T.; (...); Matthay, Katherine K.

Article. 10.1002/pbc.29616. 2022

Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.

Aparicio, J.; (...); Germa, J. R.

Article. 10.1007/s12094-020-02393-9. 2021

Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy.

Urtasun, Andrea; (...); Herrero, Maria Jose

Article. 10.3390/cancers15051424. 2023

Personalized Medicine: Learning to Walk

Gargallo, P.; (...); Canete, A.

Meeting Abstract. 2018

Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer

Oldenburg, J; (...); Spanish Germ Cell Canc Grp SGCCG

Review. 10.1093/annonc/mdu514. 2015

Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy

Margusino-Framiñán L; (...); Morillo-Verdugo R

Article. 10.7399/fh.11498. 2020

PHARMACOGENETIC VARIANTS ASSOCIATED WITH TREATMENT RESPONSE IN NEUROBLASTOMA

Olivera, G; (...); Alino, SF

Meeting Abstract. 2018

Pharmacogenetics implementation in the clinics: information and guidelines for germline variants

Olivera, Gladys; (...); Alino, Salvador F.

Review. 10.20517/cdr.2018.25. 2019

Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?

Olivera, GG; (...); Herrero, MJ

Review. 10.3390/ijms22189815. 2021

Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.2174/1389200218666171101124931. 2018

Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol

Salazar, Juliana; (...); Sebio, Ana

Article. 10.3390/pharmaceutics16121585. 2024

Pharmacogenomics and the treatment of acute myeloid leukemia

Megías-Vericat JE; (...); Aliño SF

Review. 10.2217/pgs-2016-0055. 2016

Pharmacometabolomics by NMR in Oncology: A Systematic Review.

Gómez-Cebrián N; (...); Pineda-Lucena A

Article. 10.3390/ph14101015. 2021

Pharmacotherapeutic management of advanced therapy medicinal products

Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia

Article. 10.7399/fh.13036. 2022

Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.

Calleja Hernández MÁ; (...); Aragon, B

Article. 10.7399/fh.2017.41.1.10463. 2017

Phase 1 Combination Dose-Finding/Phase 2 Expansion Cohorts of Lenvatinib plus Etoposide plus Ifosfamide in Patients Aged 2 to <= 25 Years with Relapsed/Refractory Osteosarcoma

Gaspar, N; (...); Campbell-Hewson, Q

Meeting Abstract. 2019

Phase 1 Study of Regorafenib in Combination With Vincristine and Irinotecan in Pediatric Patients With Recurrent or Refractory Solid Tumors

Casanova, M; (...); Geoerger, B

Meeting Abstract. 2020

Phase I combination dose-finding/phase II expansion cohorts of lenvatinib plus etoposide plus ifosfamide in patients (pts) aged 2 to <= 25 years with relapsed/refractory (r/r) osteosarcoma

Gaspar, N; (...); Campbell-Hewson, Q

Meeting Abstract. 2019

Phase I study of regorafenib in combination with vincristine and irinotecan in pediatric patients with recurrent or refractory solid tumors.

Casanova, Michela; (...); Geoerger, Birgit

Meeting Abstract. 2020

Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050) ? .

Gaspar N; (...); Casanova M

Article. 10.1016/j.esmoop.2021.100250. 2021

Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2

Macarulla, T; (...); Hidalgo, M

Article. 10.1200/JCO.18.00089. 2019

Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS).

Martin-Broto J; (...); Hindi N

Article. 10.1200/JCO.24.00358. 2024

Phase II trial of palbociclib in advanced sarcoma overexpressing CDK4 gene excluding dedifferentiated liposarcoma (DD LPS): A study from the Spanish Group for Research on Sarcoma (GEIS).

Broto, Javier Martin; (...); Hindi, Nadia

Meeting Abstract. 2022

Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma

Grill, J; (...); Vassal, G

Article. 10.1200/JCO.2017.76.0611. 2018

Physical Activity In Haemophilia: Hemorrhagic Risk And Factor Levels (myPKFiT)

Querol-Fuentes, F; (...); Bonanad, S

Meeting Abstract. 2017

PIER trial: Neoadjuvant therapy with panitumumab (P) and mFOLFOX-6 in an enriched population of patients with T3 rectal adenocarcinoma of the middle third with clear mesorectal fascia.

Fernandez-Martos, Carlos; (...); Vera, Ruth

Meeting Abstract. 10.1200/JCO.2018.36.4_suppl.TPS875. 2018

Pilot evaluation of home delivery programme in haemophilia

Megias-Vericat, JE; (...); Poveda-Andres, JL

Article. 10.1111/jcpt.12718. 2018

PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS

Vericat, JEM; (...); Iorio, A

Meeting Abstract. 2020

Plasma Metabolomic Profiling Differentiates High- and Low-Risk Neuroblastoma Patients

Quintas, G; (...); Segura, V

Meeting Abstract. 2018

Pleuropulmonary angiosarcoma involving the liver, the jejunum and the spine, developed from chronic tuberculosis pyothorax: Multidisciplinary approach and review of literature

Bruixola G; (...); Aparicio J

Review. 10.1016/j.lungcan.2014.07.012. 2014

Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis

Megías-Vericat JE; (...); Aliño SF

Letter. 10.1038/tpj.2015.79. 2016

Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience

Berlanga, Pablo; (...); Castel, Victoria

Article. 10.1097/MPH.0000000000000546. 2016

Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process

Valero, S; (...); Poveda, JL

Article. 10.1016/j.yrtph.2018.03.001. 2018

Precision medicine in Ewing sarcoma: a translational point of view.

Gargallo P; (...); Cañete A

Review. 10.1007/s12094-020-02298-7. 2020

Precision medicine in metastatic colorectal cancer: targeting KRAS G12C mutation

Aparicio, Jorge

Article. 10.21037/tgh-24-28. 2024

Predicting major bleeding events in anticoagulated cancer patients with venous thromboembolism using real-world data and machine learning.

Martin, Andres J. Munoz; (...); Hernandez-Presa, Miguel Angel

Meeting Abstract. 2022

Predicting recurrence of venous thromboembolism in anticoagulated cancer patients using real-world data and machine learning.

Martin, Andres J. Munoz; (...); Hernandez-Presa, Miguel Angel

Meeting Abstract. 2022

Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing.

Munoz Martin, Andres J; (...); Hernandez-Presa, Miguel Angel

Article. 10.1007/s12094-024-03586-2. 2024

Predictors of positive challenge with kiwi in children

Sabido, P; (...); Mazon, A

Meeting Abstract. 2018

PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019

Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.

García-Robles A; (...); Aguar-Carrascosa M

Letter. 10.1016/j.anpedi.2020.06.008. 2021

Preparation and administration of insulin infusions in neonatology: A national survey.

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Article. 10.1016/j.anpede.2020.06.015. 2021

Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience

Berlanga, Pablo; (...); Castel, Victoria

Article. 10.1097/MPH.0000000000000270. 2015

PRIMAGE project: predictive in silico multiscale analytics to support childhood cancer personalised evaluation empowered by imaging biomarkers.

Martí-Bonmatí L; (...); Neri E

Article. 10.1186/s41747-020-00150-9. 2020

Primary Mesenteric Undifferentiated Pleomorphic Sarcoma Masquerading as a Colon Carcinoma: A Case Report and Review of the Literature.

Diaz-Beveridge R; (...); Aparicio J

Article. 10.1155/2015/532656. 2015

Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review

Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11780. 2021

Prognosis of anaemia in disseminated testicular germ cell tumours. On behalf of the Spanish Germ Cell Cancer Group (SGCCG)

Torralba, EG; (...); Billalabeitia, EG

Meeting Abstract. 2019

Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.

Boormans, Joost L; (...); Laguna, M Pilar

Article. 10.1016/j.euo.2023.10.014. 2023

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)

Aparicio J; (...); Germà JR

Article. 10.1093/annonc/mdu437. 2014

Prognostic factors in metastatic seminomatous germ cell tumours and elevated human chorionic gonadotrophin (HCG): A study of the G3

Seidel, C; (...); Bokemeyer, C

Meeting Abstract. 2019

Prognostic factors of early mortality in children and adolescents enrolled in oncology trials with a dose-finding part in the era of targeted and immune therapies: An Innovative Therapies for Children with Cancer (ITCC) study

Carceller, Fernando; (...); Moreno, Lucas

Meeting Abstract. 2023

Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults

Article. 2014

Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy

Article. 2014

Prognostic impact of LDH and HCG levels in marker-positive seminomas

Seidel, Christoph Alexander; (...); Bokemeyer, Carsten

Meeting Abstract. 2020

PROGNOSTIC IMPACT OF TRANSPORTER GENE POLYMORPHISMS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA ADULTS

Megias Vericat, J. E.; (...); Sanz, M. A.

Article. 2015

Prognostic role of HMG proteins in a series of 301 advanced soft tissue sarcoma patients: A Spanish Group for Sarcoma Research Study (GEIS).

Hindi, N; (...); Broto, JM

Meeting Abstract. 10.1200/JCO.2018.36.15_suppl.11573. 2018

Prognostic significance of thromboembolic events in chemotherapy-treated germ cell tumors.

Gonzalez-Billalabeitia, Enrique; (...); Germa-Lluch, Jose R.

Meeting Abstract. 10.1200/jco.2015.33.15_suppl.4536. 2015

Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients

Gonzalez-Billalabeitia, E; (...); Spanish Germ Cell Cancer Group

Article. 10.1093/jnci/djw265. 2017

Progressively transformed germinal center (PTGC): a challenging diagnosis. Four new pediatric cases

Andres, MM; (...); Fernandez, JM

Meeting Abstract. 2018

Prostaglandin Injection After Arterial Compromise Related to Hyaluronic Acid Filler

Letter. 10.1097/DSS.0000000000001046. 2017

Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages.

Juan Ribelles A; (...); Castel V

Correction. 10.1038/s41598-020-58428-2. 2020

Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker

Perez-Alenda, S; (...); Querol, F

Letter. 10.1111/hae.13388. 2018

Radiological evaluation of newly diagnosed non-brainstem pediatric high-grade glioma in the HERBY phase II trial.

Rodriguez Gutierrez D; (...); Jaspan T

Article. 10.1158/1078-0432.CCR-19-3154. 2020

Radiotherapy quality assurance in paediatric clinical trials: first report from six QUARTET-affiliated trials.

Kelly, Sarah M.; (...); Mandeville, Henry

Article. 10.1016/j.radonc.2023.109549. 2023

Ramucirumab effectiveness in patients with advanced gastric cancer or gastro-esophageal junction adenocarcinoma in clinical practice in Spain: Sub-analysis of RAMIS study

Longo, F; (...); Sedano, MO

Meeting Abstract. 10.1016/j.annonc.2020.04.125. 2020

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer

Dalgleish, AG; (...); Mudan, SS

Article. 10.1038/bjc.2016.271. 2016

Randomized phase II clinical trial to evaluate the efficacy of second line FOLFIRI-panitumumab in patients with RAS wild -type metastatic colorectal cancer who have received FOLFOXpanitumumab in first -line (BEYOND)

Aparicio, J; (...); Maurel, J

Meeting Abstract. 10.1093/annonc/mdz155.190. 2019

Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)

Aparicio, Jorge; (...); Maurel, Joan

Article. 10.1007/s12094-022-02868-x. 2022

Randomized phase II trial of second-line FOLFIRI-panitumumab vs FOLFIRI alone in Ras wild type (wt) metastatic colorectal cancer (mCRC) patients beyond progression to first-line FOLFOX-panitumumab: BEYOND study (GEMCAD 17-01)

Aparicio, J; (...); Maurel, J

Meeting Abstract. 10.1016/j.annonc.2021.08.937. 2021

Rapidly progressive frontal necrotic plaque in an immunosuppressed host